CAMBRIDGE, Mass.-(BUSINESS WIRE) - Data from an observational phase IV study of 499 patients entitled The Swiss MS Skin Project show that multiple sclerosis (MS) patients taking AVONEX (interferon ...

Dosing Enhancements May Improve Treatment Experience for Patients Receiving AVONEX® (interferon beta-1a) for Multiple Sclerosis WESTON, Mass.--(BUSINESS WIRE)--Today Biogen Idec (NASDAQ: BIIB) ...

CAMBRIDGE, MA – Sept. 11, 2009 – Data from an observational phase IV study of 499 patients entitled The Swiss MS Skin Project show that multiple sclerosis (MS) patients taking AVONEX (interferon ...

European Commission approves the first single-use intramuscular autoinjector designed to improve convenience of once-weekly AVONEX (interferon beta-1a) administration “At Biogen Idec, our commitment ...

-- First single-use intramuscular autoinjector designed to improve convenience of once-weekly AVONEX recommended for approval in the European Union and authorised in Canada -- AVONEX PEN is designed ...

According to Drugmaker Biogen Idec this Tuesday, it has received U.S. approval for an easier-to-use form of its multiple sclerosis injection Avonex. The Food and Drug Administration approved the ...

Biogen Idec BIIB today announced the findings from a randomized, multicenter, dose-blinded clinical trial that evaluated the effect of AVONEX dose titration, or gradual dose escalation, on flu-like ...

Biogen Idec announced the national launch of the new AVONEX(R) (Interferon beta-1a) Nurse Services program which is designed to help people with multiple sclerosis (MS) as they begin and continue ...

Serono SA released impressive 24-week data from its 677-patient, head-to-head study of its product Rebif vs. Biogen Inc. s Avonex in patients with relapsing-remitting multiple sclerosis, and is ...

Under the clarification, only Medicare beneficiaries going to a doctor's office for an Avonex injection once a week are eligible for reimbursement. Medicare will not cover three other injectable drugs ...

AVONEX PEN (interferon beta-1a) 30mcg/0.5mL solution for injection by Biogen Idec Biogen Idec has received approval from the FDA for Avonex Pen (30mcg/0.5mL solution for injection) for patients ...